Bruker Corporation (NASDAQ:BRKR) previous close was $68.07 while the outstanding shares total 151.80M. The firm has a beta of 1.30, a 12-month trailing P/E ratio of 51.73, and a growth ratio of 5.36. BRKR’s shares traded higher over the last trading session, gaining 0.69% on 06/03/21. The shares fell to a low of $67.78 before closing at $68.54. Intraday shares traded counted 0.63 million, which was -26.33% lower than its 30-day average trading volume of 501.11K. The stock’s Relative Strength Index (RSI) is 51.03, with weekly volatility at 2.05% and ATR at 1.76. The BRKR stock’s 52-week price range has touched low of $36.82 and a $71.28 high.
Investors have identified the Medical Devices company Bruker Corporation as an interesting stock but before investments are made there, an in-depth look at its trading activities will have to be conducted. The share is trading with a market value of around $10.39 billion, the company now has both obstacles and catalysts that affect them and they came from their mode of operations. With the company affected by events currently, it is a perfect time to analyze the numbers behind the firm in order to come up with a rather realistic picture of what this stock is.
Bruker Corporation (BRKR) Fundamentals that are to be considered.
When analyzing a stock, the first fundamental thing to take into account is the balance sheet. How healthy the balance sheet of a company is will determine if the company will be able to carry out all its financial and non-financial obligations and also keep the faith of its investors. For BRKR, the company has in raw cash 696.8 million on their books with 108.4 million currently as liabilities. How the trend is over time is what investors should be concerned about. The company has a healthy balance sheet as their debt profile has been on an incline. In terms of their assets, the company currently has 1.95 billion total, with 943.5 million as their total liabilities.
BRKR were able to record 73.3 million as free cash flow during the 08/05/2021 quarter of the year, this saw their quarterly net cash flow reduce by 14.9 million. In cash movements, the company had a total of 98.0 million as operating cash flow.
Potential earnings growth for Bruker Corporation (BRKR)
In order to determine the future investment potential for this stock, we will have to analyze key trends that affect it. During the 08/05/2021 quarter of the year, Bruker Corporation recorded a total of 554.7 million in revenue. This figure implies that they witnessed a quarterly year/year change in their earnings with 23.56% coming in sequential stages and their sales for the 08/05/2021 quarter reducing by -13.12%.
What matters though is how it ends. When the core data for the company is broken down, then the stock sounds interesting. The company spent 276.0 million trying to sell their products during the last quarter, with the result yielding a gross income of 278.7 million. This allows shareholders to hold on to 151.80M with the recently reported earning now reading 0.38 cents per share. This is a figure that compared to analyst’s prediction for their 08/05/2021 (0.44 cents a share).
Having a look at the company’s valuation, the company is expected to record 2.10 total earnings per share during the next fiscal year. It is very important though to remember that the importance of trend far outweighs that of outlook. This analysis has been great and getting further updates on BRKR sounds very interesting.
Is the stock of BRKR attractive?
In related news, Director, Friend Cynthia M sold 1,800 shares of the company’s stock in a transaction that recorded on Mar 22. The sale was performed at an average price of 60.43, for a total value of 108,766. As the sale deal closes, the Director, Kastner Marc A now sold 1,236 shares of the company’s stock, valued at 69,908. Also, Director, Friend Cynthia M sold 1,800 shares of the company’s stock in a deal that was recorded on Dec 21. The shares were price at an average price of 54.32 per share, with a total market value of 97,776. Following this completion of acquisition, the Director, Friend Cynthia M now holds 3,473 shares of the company’s stock, valued at 190,841. In the last 6 months, insiders have changed their ownership in shares of company stock by 0.20%.
4 out of 13 analysts covering the stock have rated it a Buy, while 8 have maintained a Hold recommendation on Bruker Corporation. 1 analysts has assigned a Sell rating on the BRKR stock. The 12-month mean consensus price target for the company’s shares has been set at $72.58.